Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Review

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

       
Total article views   HTML views PDF downloads Totals
8,708 Dovepress* 8,708+ 2,702 11,410
Totals 8,708 2,702 11,410
*Since 13 March 2012
+Since July 2016

View citations on Google Scholar